Abstract
Novel treatments for androgen independent prostate cancer are needed since most men who relapse after a period of androgen ablation therapy have a poor prognosis. Previously we demonstrated that purine-rich element binding protein, PUR alphaμ was significantly repressed in androgen-independent prostate cancer cell lines in comparison to an androgen-dependent line. Furthermore, over-expressing PUR alpha in androgen-independent prostate cancer cells attenuated their proliferation. The aim of this study was to uncover some of the mechanisms by which PUR alpharegulate cell growth and to determine if the pathways regulated by PUR alpha may serve as targets to develop novel therapeutic interventions in hormone-refractory prostate cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
